Head of PharmaTox recives ERC Starting Grant!

Professor Hedvig Nordeng has receieved an ERC Starting Grant for the project entitled "Effects of Medication Use in Pregnancy on Infant Neurodevelopment (DrugsInPregnancy)."

The project will run for five years and has been awarded 1.5 Million Euro.

Head of PharmaTox Hedvig Nordeng receives ERC Starting Grant

Published Mar. 6, 2015 3:53 PM - Last modified Sep. 19, 2019 2:28 PM
E-mail this page